Attitudes Toward HIV Pre-Exposure Prophylaxis in a United States Urban Clinic Population

被引:0
作者
Helena A. Kwakwa
Sophia Bessias
Donielle Sturgis
Natasha Mvula
Rahab Wahome
Catelyn Coyle
Timothy P. Flanigan
机构
[1] Philadelphia Department of Public Health,Division of Ambulatory Health Services
[2] AIDS Care Group,Division of Infectious Diseases
[3] National Nursing Centers Consortium,undefined
[4] Brown University Alpert School of Medicine,undefined
来源
AIDS and Behavior | 2016年 / 20卷
关键词
PrEP; HIV; Urban; Attitudes; US;
D O I
暂无
中图分类号
学科分类号
摘要
A majority of US studies on attitudes toward PrEP focus on men who have sex with men with little representation of African Americans. This cross-sectional study seeks to determine openness to PrEP, and examine motivations for openness among Philadelphia residents. Patients undergoing HIV rapid testing between May 2012 and December 2014 in a public setting were administered a survey. Questions included openness to PrEP and reasons for openness to PrEP. Multivariate logistic regression models were used to investigate associations between openness and potential predictors. Analyses were conducted using R version 3.2.4 and the epitools and car packages. Of 5606 respondents, over 90 % were African American. Men were more likely to express openness (61.4 % of men, 54.8 % of women, p < 0.0001). Predictors of openness were younger age, black race, higher perceived risk for HIV by patient or as assessed by Tester, intermittent /no condom use, greater number of partners in 12 months and previous HIV testing. The main reason for openness was fear of HIV, and for disinterest was lack of recognition of risk. Understanding openness to PrEP, and reasons for openness to or disinterest in PrEP are critical to determining the best approaches to facilitate engagement in PrEP care by communities and persons at elevated risk for HIV acquisition. Further study is needed on how best to manage disinterest in PrEP by those at high risk for HIV, and how openness to PrEP translates into concrete steps to take PrEP.
引用
收藏
页码:1443 / 1450
页数:7
相关论文
共 136 条
[1]  
Grant RM(2010)Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 2587-2599
[2]  
Lama JR(2013)Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomized, double-blind, placebo-controlled phase 3 trial The Lancet 381 2083-2090
[3]  
Anderson PL(2012)Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N Engl J Med 367 399-410
[4]  
McMahan V(2012)Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana N Engl J Med 367 423-434
[5]  
Liu AY(2013)Efficacy of pre-exposure prophylaxis for HIV-1 prevention among high risk heterosexuals: subgroup analyses from a randomized trial AIDS 27 2155-2160
[6]  
Vargas L(2014)HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention J Acquir Immune Defic Syndr 66 340-348
[7]  
Choopanya K(2015)Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition—United States, 2015 MMWR Morb Mortal Wkly Rep 64 1291-1295
[8]  
Martin M(2012)Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study PLoS ONE 7 e28238-829
[9]  
Suntharasamai P(2015)Knowledge, attitudes, and experiences of HIV pre-exposure prophylaxis (PrEP) trial participants in Botswana World J AIDS 5 10-477
[10]  
Sangkum U(2014)Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study Lancet Infect Dis. 14 820-691